Piperacillin-tazobactam-induced acute interstitial nephritis with possible meropenem cross-sensitivity in a patient with osteomyelitis.
Tina J
TJ
Liu
Joseph P
JP
Lam
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004347:Drug Interactions / Q000276:immunology; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D008297:Male; D000077731:Meropenem; D008875:Middle Aged; D009395:Nephritis, Interstitial / Q000139:chemically induced*; D010019:Osteomyelitis / Q000188:drug therapy*; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D010878:Piperacillin / Q000009:adverse effects; D000077725:Piperacillin, Tazobactam Drug Combination; D013845:Thienamycins / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D000077731:Meropenem; D010878:Piperacillin